Highland Capital Management LLC increased its position in UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 1.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,475 shares of the healthcare conglomerate’s stock after acquiring an additional 230 shares during the quarter. Highland Capital Management LLC’s holdings in UnitedHealth Group were worth $ 10,442,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Outfitter Financial LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at approximately $ 25,000. Blue Bell Private Wealth Management LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at approximately $ 29,000. Advocacy Wealth Management Services LLC grew its holdings in UnitedHealth Group by 75.8% during the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $ 30,000 after buying an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. grew its holdings in UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $ 31,000 after buying an additional 30 shares in the last quarter. Finally, Tortoise Investment Management LLC grew its holdings in UnitedHealth Group by 54.8% during the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $ 33,000 after buying an additional 23 shares in the last quarter. 87.48% of the stock is owned by institutional investors.
Shares of UnitedHealth Group stock opened at $ 515.71 on Thursday. The firm has a market cap of $ 483.82 billion, a P / E ratio of 28.23, a P / E / G ratio of 1.54 and a beta of 0.83. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a 12 month low of $ 383.12 and a 12 month high of $ 553.29. The stock’s fifty day moving average price is $ 493.31 and its 200-day moving average price is $ 492.11.
UnitedHealth Group (NYSE: UNH – Get Rating) last announced its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 EPS for the quarter, beating the consensus estimate of $ 5.40 by $ 0.09. The firm had revenue of $ 80.15 billion for the quarter, compared to analyst estimates of $ 78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The business’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter last year, the firm posted $ 5.31 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were paid a dividend of $ 1.65 per share. The ex-dividend date was Thursday, June 16th. This represents a $ 6.60 annualized dividend and a dividend yield of 1.28%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $ 1.45. UnitedHealth Group’s dividend payout ratio (DPR) is currently 36.12%.
A number of research analysts have recently commented on the company. SVB Leerink increased their target price on UnitedHealth Group from $ 550.00 to $ 600.00 and gave the company an “outperform” rating in a research report on Tuesday, April 19th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $ 613.00 to $ 612.00 and set an “overweight” rating for the company in a research report on Wednesday, May 25th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $ 482.00 to $ 549.00 and gave the company a “buy” rating in a research report on Monday, April 18th. Cowen raised their price target on UnitedHealth Group from $ 512.00 to $ 596.00 in a research report on Monday, April 18th. Finally, Truist Financial raised their price target on UnitedHealth Group from $ 575.00 to $ 610.00 in a research report on Thursday, April 7th. Three analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $ 555.73.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction dated Monday, May 16th. The stock was sold at an average price of $ 493.25, for a total value of $ 1,233,125.00. Following the transaction, the director now owns 1,220,000 shares in the company, valued at $ 601,765,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Frederick William Mcnabb III bought 89 shares of the business’s stock in a transaction on Thursday, May 26th. The stock was bought at an average price of $ 504.32 per share, for a total transaction of $ 44,884.48. Following the purchase, the director now directly owns 11,259 shares of the company stock, valued at $ 5,678,138.88. The disclosure for this purchase can be found here. Insiders sold 6,273 shares of company stock worth $ 3,065,752 in the last quarter. 0.40% of the stock is owned by insiders.
UnitedHealth Group Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.